CytoDyn Inc.
CYDYOTCHealthcare● Active
$0.30
+$0.01(+2.15%)
Market Cap$409139434
P/E Ratio—
52W High$0.4
52W Low$0.21
CytoDyn Inc. (CYDY) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CYDY · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 8, 2026EPS Actual
-$0.00
Est. -$0.05 · +92.0%
Revenue
—
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 8, 2026
After Market Close
▲ Beat EPS✓ 2-Quarter EPS Beat Streak
CYDY reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $6.21B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$6.21B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 29, 2026 | -$0.05 | — | — | — | — | — |
| ◌ Q2 FY2026 | Apr 29, 2026 | — | — | — | — | — | — |
| ▲ Q2 FY2026 | Apr 8, 2026 | -$0.05 | -$0.00 | +92.0% | — | — | — |
| ▲ Q1 FY2026 | Jan 9, 2026 | -$0.05 | -$0.01 | +80.0% | — | — | — |
| — Q4 FY2025 | Oct 10, 2025 | — | -$0.00 | — | — | — | — |
| — Q3 FY2025 | Jul 25, 2025 | — | -$0.01 | — | $-0.01B | — | — |
| — Q2 FY2025 | Apr 14, 2025 | — | -$0.00 | — | — | — | — |
| — Q1 FY2025 | Jan 14, 2025 | — | -$0.00 | — | — | — | — |
Q3 FY2026
Jul 29, 2026
EPS Actual
—
EPS Est.
-$0.05
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 29, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 8, 2026Beat
EPS Actual
-$0.00
EPS Est.
-$0.05
EPS Surpr.
+92.0%
Revenue
—
Q1 FY2026
Jan 9, 2026Beat
EPS Actual
-$0.01
EPS Est.
-$0.05
EPS Surpr.
+80.0%
Revenue
—
Q4 FY2025
Oct 10, 2025
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2025
Jul 25, 2025
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$-0.01B
Q2 FY2025
Apr 14, 2025
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2025
Jan 14, 2025
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2028 | $-0.04 | $-0.04 | $-0.04 | 1 |
| Q4 FY2027 | $-0.04 | $-0.04 | $-0.04 | 1 |
| Q3 FY2027 | $-0.04 | $-0.04 | $-0.04 | 1 |
| Q2 FY2027 | $-0.04 | $-0.04 | $-0.04 | 1 |
| Q1 FY2027 | $-0.04 | $-0.04 | $-0.04 | 1 |
| Q4 FY2026 | $-0.05 | $-0.05 | $-0.05 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2028 | $0.0B | $0.0B | $0.0B | 0 |
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | Apr 8, 2026 | +92.0% | $0.27 | $0.28 | +4.09% |
| ▲ Q1 FY2026 | Jan 9, 2026 | +80.0% | $0.28 | $0.27 | -2.84% |
| — Q4 FY2025 | Oct 10, 2025 | — | $0.26 | $0.26 | +0.81% |
| — Q3 FY2025 | Jul 25, 2025 | — | $0.29 | $0.30 | +1.05% |
| — Q2 FY2025 | Apr 14, 2025 | — | $0.21 | $0.20 | -2.43% |
| — Q1 FY2025 | Jan 14, 2025 | — | $0.15 | $0.15 | +1.00% |
| — Q4 FY2024 | Oct 15, 2024 | — | $0.15 | $0.14 | -0.41% |
| — Q3 FY2024 | Aug 15, 2024 | — | $0.13 | $0.12 | -10.69% |
Q2 FY2026+4.09%
Report Date
Apr 8, 2026
EPS Beat/Miss
+92.0%
Price Before
$0.27
Price After
$0.28
Q1 FY2026-2.84%
Report Date
Jan 9, 2026
EPS Beat/Miss
+80.0%
Price Before
$0.28
Price After
$0.27
Q4 FY2025+0.81%
Report Date
Oct 10, 2025
EPS Beat/Miss
—
Price Before
$0.26
Price After
$0.26
Q3 FY2025+1.05%
Report Date
Jul 25, 2025
EPS Beat/Miss
—
Price Before
$0.29
Price After
$0.30
Q2 FY2025-2.43%
Report Date
Apr 14, 2025
EPS Beat/Miss
—
Price Before
$0.21
Price After
$0.20
Q1 FY2025+1.00%
Report Date
Jan 14, 2025
EPS Beat/Miss
—
Price Before
$0.15
Price After
$0.15
Q4 FY2024-0.41%
Report Date
Oct 15, 2024
EPS Beat/Miss
—
Price Before
$0.15
Price After
$0.14
Q3 FY2024-10.69%
Report Date
Aug 15, 2024
EPS Beat/Miss
—
Price Before
$0.13
Price After
$0.12
Avg Beat Reaction+0.63%
Beat Rate2 / 8 quarters
Largest Move-10.69% (Q3 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CYDY ends December
CytoDyn Inc. (CYDY) most recently reported earnings on April 8, 2026 for Q2 FY2026, posting EPS of $-0.00 — beating the analyst consensus of $-0.05 by +92.0%. CYDY has beaten EPS estimates for 2 consecutive quarters. The next CYDY earnings date is expected around September 1, 2026.
Each quarter, investors track CYDY earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CYDY revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CYDY's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CYDY earnings · 5 questionsCytoDyn Inc.'s next earnings report is expected around September 1, 2026. CYDY typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CYDY historically reports after market close (AMC).
CYDY earnings datewhen is CYDY earningsCYDY next earnings datewhen does CYDY report earningsCYDY earnings calendar
▸ Source: FMP · CytoDyn Inc. SEC filings · US GAAP · CytoDyn Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026